Sage Journals: Discover world-class research

Abstract

Sjogren's syndrome (SS) is a complex systemic autoimmune disease. This study aims to elucidate a humanized NOD-Prkdc^scidIl2rg^em1/Smoc (NSG) murine model to better clarify the pathogenesis of SS. NSG female mice were adoptively transferred with 10 million peripheral blood mononuclear cells (PBMCs) through the tail vein from healthy controls (HCs), primary Sjogren's syndrome (pSS), and systemic lupus erythematosus (SLE) patients on D0. The mice were subcutaneously injected with C57/B6j submandibular gland (SG) protein or phosphate-buffered saline on D3, D17 and D31, respectively. NSG mice were successfully transplanted with human PBMCs. Compared with NSG-HC group, NSG-pSS and NSG-SLE mice exhibited a large number of lymphocytes infiltration in the SG, decreased salivary flow rate, lung involvement, decreased expression of genes related to salivary secretion, and the production of autoantibodies. Type I interferon-related genes were increased in the SG of NSG-pSS and NSG-SLE mice. The ratio of BAX/BCL2, BAX, cleaved caspase3, and TUNEL staining were increased in the SG of NSG-pSS and NSG-SLE mice. The expressions of p-MLKL and p-RIPK3 were increased in the SG of NSG-pSS and NSG-SLE mice. Increased expression of type I interferon-related genes, PANoptosis (apoptosis and necroptosis) were identified in the SG of this typical humanized NSG murine model of SS.

Get full access to this article

View all access options for this article.

References

Ambrosi

, Wahren-Herlenius

. Update on the immunobiology of Sjogren's syndrome. Curr Opin Rheumatol, 2015; 27(5):468–475; doi: 10.1097/BOR.0000000000000195

Aringer

. EULAR/ACR classification criteria for SLE. Semin Arthritis Rheum, 2019; 49(3S):S14–S17; doi: 10.1016/j.semarthrit.2019.09.009

Bertheloot

, Latz

, Franklin

. Necroptosis, pyroptosis and apoptosis: An intricate game of cell death. Cell Mol Immunol, 2021; 18(5):1106–1121; doi: 10.1038/s41423-020-00630-3

Bodewes

ILA

, Versnel

. Interferon activation in primary Sjogren's syndrome: Recent insights and future perspective as novel treatment target. Expert Rev Clin Immunol, 2018; 14(10):817–829; doi: 10.1080/1744666X.2018.1519396

Bombardier

, Gladman

, Urowitz

, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992; 35(6):630–640.

Brandt

, Priori

, Valesini

, et al. Sex differences in Sjogren's syndrome: A comprehensive review of immune mechanisms. Biol Sex Differ, 2015; 6:19; doi: 10.1186/s13293-015-0037-7

Brkic

, Versnel

. Type I IFN signature in primary Sjogren's syndrome patients. Expert Rev Clin Immunol, 2014; 10(4):457–467; doi: 10.1586/1744666X.2014.876364

Fernandez-Ruiz

, Niewold

. Type I interferons in autoimmunity. J Invest Dermatol, 2022; 142(3 Pt B):793–803; doi: 10.1016/j.jid.2021.11.031

Fox

. Sjogren's syndrome. Lancet, 2005; 366(9482):321–331; doi: 10.1016/S0140-6736(05)66990-5

10.

Gao

, Chen

, Zhang

, et al. Recent advances in mouse models of Sjogren's syndrome. Front Immunol, 2020; 11:1158; doi: 10.3389/fimmu.2020.01158

11.

Hong

, Lee

, Jang

, et al. Type I interferon increases inflammasomes associated pyroptosis in the salivary glands of patients with primary Sjogren's syndrome. Immune Netw, 2020; 20(5):e39; doi: 10.4110/in.2020.20.e39

12.

Huijser

, Versnel

. Making sense of intracellular nucleic acid sensing in type I interferon activation in Sjogren's syndrome. J Clin Med, 2021; 10(3):532; doi: 10.3390/jcm10030532

13.

Hwang

, Woo

, Moon

, et al. IL-17 and CCR9(+)alpha4beta7(−) Th17 cells promote salivary gland inflammation, dysfunction, and cell death in Sjogren's syndrome. Front Immunol, 2021; 12:721453; doi: 10.3389/fimmu.2021.721453

14.

Imgenberg-Kreuz

, Sandling

, Nordmark

. Epigenetic alterations in primary Sjogren's syndrome - an overview. Clin Immunol, 2018; 196:12–20; doi: 10.1016/j.clim.2018.04.004

15.

Jiang

, Zhao

, Chang

, et al. Type I interferons in the pathogenesis and treatment of autoimmune diseases. Clin Rev Allergy Immunol, 2020; 59(2):248–272; doi: 10.1007/s12016-020-08798-2

16.

Ketelut-Carneiro

, Fitzgerald

. Apoptosis, Pyroptosis, and Necroptosis-Oh My! The Many Ways a Cell Can Die. J Mol Biol, 2022; 434(4):167378; doi: 10.1016/j.jmb.2021.167378

17.

, Ice

, Lessard

, et al. Interferons in Sjogren's Syndrome: Genes, Mechanisms, and Effects. Front Immunol, 2013; 4:290; doi: 10.3389/fimmu.2013.00290

18.

Lin

, Rui

, Deng

, et al. Th17 cells play a critical role in the development of experimental Sjogren's syndrome. Ann Rheum Dis, 2015; 74(6):1302–1310; doi: 10.1136/annrheumdis-2013-204584

19.

Lin

, Song

, Shaw

, et al. An autoimmunized mouse model recapitulates key features in the pathogenesis of Sjogren's syndrome. Int Immunol, 2011; 23(10):613–624; doi: 10.1093/intimm/dxr066

20.

Manganelli

, Fietta

. Apoptosis and Sjogren syndrome. Semin Arthritis Rheum, 2003; 33(1):49–65; doi: 10.1053/sarh.2003.50019

21.

Marketos

, Cinoku

, Rapti

, et al. Type I interferon signature in Sjogren's syndrome: Pathophysiological and clinical implications. Clin Exp Rheumatol, 2019; 37 Suppl 118(3):185–191.

22.

Mihaylova

, Chipinski

, Bradyanova

, et al. Suppression of autoreactive T and B lymphocytes by anti-annexin A1 antibody in a humanized NSG murine model of systemic lupus erythematosus. Clin Exp Immunol, 2020; 199(3):278–293; doi: 10.1111/cei.13399

23.

Nakamura

, Horai

, Shimizu

, et al. Modulation of apoptosis by cytotoxic mediators and cell-survival molecules in Sjogren's syndrome. Int J Mol Sci, 2018; 19(8):2369; doi: 10.3390/ijms19082369

24.

Nocturne

, Mariette

. Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol, 2013; 9(9):544–556; doi: 10.1038/nrrheum.2013.110

25.

Pandian

, Kanneganti

. PANoptosis: A unique innate immune inflammatory cell death modality. J Immunol, 2022; 209(9):1625–1633; doi: 10.4049/jimmunol.2200508

26.

Qin

, Wang

, Yang

, et al. Epidemiology of primary Sjogren's syndrome: A systematic review and meta-analysis. Annu Rheum Dis, 2015; 74(11):1983–1989; doi: 10.1136/annrheumdis-2014-205375

27.

Scardina

, Spano

, Carini

, et al. Diagnostic evaluation of serial sections of labial salivary gland biopsies in Sjogren's syndrome. Med Oral Patol Oral Cir Bucal, 2007; 12(8):E565–E568.

28.

Scuron

, Fay

, Oliver

, et al. Spontaneous model of Sjogren's Syndrome in NOD mice. Curr Protoc Pharmacol, 2019; 86(1):e65; doi: 10.1002/cpph.65

29.

Seror

, Bowman

, Brito-Zeron

, et al. EULAR Sjögren's syndrome disease activity index (ESSDAI): A user guide. RMD Open, 2015; 1(1):e000022; doi: 10.1136/rmdopen-2014-000022

30.

Sisto

, Ribatti

, Lisi

. Molecular mechanisms linking inflammation to Autoimmunity in Sjogren's syndrome: Identification of new targets. Int J Mol Sci, 2022; 23(21):13229; doi: 10.3390/ijms232113229

31.

Vitali

, Bombardieri

, Jonsson

, et al. Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis, 2002; 61(6):554–558; doi: 10.1136/ard.61.6.554

32.

Walsh

, Kenney

, Jangalwe

, et al. Humanized mouse models of clinical disease. Annu Rev Pathol, 2017; 12:187–215; doi: 10.1146/annurev-pathol-052016-100332

33.

Wen

, Xu

, et al. Retinoic acid receptor-related orphan nuclear receptor gammat licenses the differentiation and function of a unique subset of follicular helper T cells in response to immunogenic self-DNA in systemic lupus erythematosus. Arthritis Rheumatol, 2021; 73(8):1489–1500; doi: 10.1002/art.41687

34.

Xiao

, Han

, Wang

, et al. Animal models of Sjogren's syndrome: An update. Clin Exp Rheumatol, 2019; 37 Suppl 118(3):209–216.

35.

Yao

, Liu

, Jallal

, et al. Type I interferons in Sjogren's syndrome. Autoimmun Rev, 2013; 12(5):558–566; doi: 10.1016/j.autrev.2012.10.006

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.75 MB

0.84 MB

PANoptosis Features,a Humanized NSG Murine Model of Sjogren's Syndrome

Abstract

Get full access to this article

References

Supplementary Material